Profilo in breve:
Established in 2011 Exosomics S.p.A. was founded with the intent to validate a wide panel of biomarkers to diagnose cancer at an early stage. In particular, the company’s aim is to develop, validate and manufacture products and to provide services for exosome-based diagnostics.
Exosomics’ laboratories are located at the Medicines Research Center of Toscana Life Sciences.
The company has a qualified management team that guides the operational and scientific aspects as well as the strategic alliances and business development.
Exosomics collaborates with several national and international research groups for the development of the technologies and products described above, and it has become a global leader in the field of exosome-based diagnostics.
